SAHPRA calls for Increased National Treasury funding

The SA Health Products Regulatory Authority (SAHPRA) has appealed to the National Treasury for more funding, warning of operational risks due to over-reliance on fee income.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged government funding, health product regulation, Mpox vaccine, National Treasury, Pharmaceutical Industry, SAHPRA, South African healthcare